Discover how HER2 gene suppression of PPARγ in breast cancer creates new therapeutic opportunities through combination drug therapy.
Exploring how anti-HER2 immunoliposomes deliver EPR imaging probes to detect HER2-positive breast cancer micrometastases with unprecedented precision.